Key Highlights
- World Hepatitis Day 2025 honors Dr. Baruch Blumberg’s discovery of the Hepatitis B virus and the first vaccine.
- The theme "Hepatitis: Let’s Break It Down" focuses on dismantling financial, social, and systemic barriers to care.
- Universal vaccination, early diagnosis, and stigma‑reduction campaigns form the core of the global strategy.
- WHO’s 2030 goal is to eliminate hepatitis as a public health threat worldwide.
Detailed Insights
Hepatitis is an inflammation of the liver, the organ that detoxifies, metabolises, and stores energy. It can be acute or chronic; chronic forms silently erode liver function over years, potentially leading to cirrhosis, liver failure, or hepatocellular carcinoma. While viral infections dominate, alcohol abuse, autoimmune disorders, and certain medications also trigger hepatitis.
Transmission pathways vary by type: Hepatitis A and E spread through contaminated food or water; Hepatitis B transmits via infected blood, unprotected sex, or mother‑to‑child during delivery; Hepatitis C spreads through blood‑to‑blood contact, often via unsafe injections; Hepatitis D requires co‑infection with Hepatitis B to replicate; Hepatitis C is now curable with antiviral therapy.
Early symptoms—fatigue, loss of appetite, nausea, abdominal pain, dark urine, pale stools, and jaundice—are often subtle, especially in chronic cases where signs appear only after significant damage. Children are at risk of silent infection through vertical transmission or contaminated resources, underscoring the need for vaccination and routine screening.
Long‑term complications of chronic hepatitis B and C include liver cirrhosis, liver failure, hepatocellular carcinoma, portal hypertension, and the potential need for transplantation. Timely antiviral treatment, lifestyle modifications, and regular monitoring can markedly reduce these risks.
Prevention hinges on vaccination for Hepatitis A and B, safe food and water practices, sterile medical procedures, screened blood transfusions, protected sexual activity, avoidance of shared personal items, and regular testing for high‑risk groups.
Screening methods encompass blood tests for viral markers and liver enzymes, liver function tests, imaging for scarring, and biopsy in advanced disease. At‑risk populations include those with a family history of hepatitis, recipients of unscreened transfusions, pregnant women, and individuals exhibiting jaundice or unexplained fatigue.
Awareness campaigns on World Hepatitis Day encourage testing, vaccination drives, social media outreach, and open conversations to dismantle stigma and misinformation.